Leonteq Securities AG’s Nymox Pharmaceutical Corp NYMX Stock Holding History

Leonteq Securities AG’s Portfolio NYMX Stock Details NYMX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q4	–	Sell	-64,999	Closed	-$27.4K	–	1379
2022 Q3	$27.4K	Hold	64,999	–	–	﹤0.01%	919
2022 Q2	$28.3K	Sell	64,999 -10,000	-13%	-$9.2K	﹤0.01%	932
2022 Q1	$94.5K	Hold	74,999	–	–	﹤0.01%	745
2021 Q4	$97.5K	Sell	74,999 -4,998	-6%	-$7.97K	﹤0.01%	781
2021 Q3	$165K	Hold	79,997	–	–	0.01%	627
2021 Q2	$126K	Hold	79,997	–	–	0.01%	673
2021 Q1	$178K	Hold	79,997	–	–	0.01%	569
2020 Q4	$198K	Buy	+79,997	New	+$177K	0.01%	569

Other funds holding NYMX

FDCDDQ

Federation des caisses Desjardins du Quebec Levis, Quebec, Canada $32.7B AUM 35.71% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

Citadel Advisors Miami, Florida $875B AUM 40.91% 1-Year Est. Return

BFG

Bleakley Financial Group Fairfield, New Jersey $7.85B AUM 31.48% 1-Year Est. Return

CAN

Cetera Advisor Networks El Segundo, California $20.2B AUM 22.31% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Susquehanna International Group Bala Cynwyd, Pennsylvania $1.28T AUM 58.89% 1-Year Est. Return

FCFC

First Citizens Financial Corp Mason City, Iowa $239M AUM 26.56% 1-Year Est. Return

Leonteq Securities AG's NYMX Position: Q4 2022 in Review

Leonteq Securities AG sold out of Nymox Pharmaceutical Corp (NYMX) in Q4 2022, closing a stake of 64,999 shares — an estimated $27.4K sold.

Leonteq Securities AG first reported a position in NYMX in Q4 2020 and held it in 8 quarters. The position peaked at $198K in Q4 2020. 37 funds tracked by Wall St. Rank hold NYMX as of Q4 2022.

Leonteq Securities AG reported no remaining Nymox Pharmaceutical Corp position as of Q4 2022 after selling out during the quarter.
Leonteq Securities AG sold 64,999 Nymox Pharmaceutical Corp shares in Q4 2022, an estimated $27.4K.
Leonteq Securities AG first reported a position in Nymox Pharmaceutical Corp in Q4 2020 and held it in 8 quarters.
Leonteq Securities AG's Nymox Pharmaceutical Corp position peaked at $198K in Q4 2020.
37 funds tracked by Wall St. Rank held Nymox Pharmaceutical Corp as of Q4 2022.

Based on Leonteq Securities AG's 13F filing for Q4 2022, filed 26 Mar 2026.